FMC

FMC Corporation Q1 2008 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2008. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company reported strong performance across all segments, driven by higher sales volumes and selling prices, partially offset by rising raw material and energy costs.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenue increased 11.3% year-over-year, driven by growth in all three segments. Agricultural Products revenue rose 11.8%, Specialty Chemicals 10.5%, and Industrial Chemicals 11.4%.
• Profitability: Net income more than doubled to $93.9 million. This was significantly aided by a net gain of $8.3 million in "Restructuring and other charges (income)" compared to a $24.3 million charge in the prior year.
• Asset Sales: The company recognized a $29.6 million gain from the sale of its Princeton research center and a $3.6 million gain from the sale of sodium sulfate assets.
• Restructuring Charges: Despite the gains, the company recorded $15.8 million in charges related to the phase-out of its Baltimore facility and $3.2 million in severance costs.
• Cash Flow: Operating cash flow remained negative ($54.5 million outflow) due to increases in trade receivables and inventory, though investing activities provided $44.6 million due to asset sales.

Guidance, Outlook, and Risks

• Full-Year Outlook:
  • Agricultural Products: Revenue growth expected in high single digits; operating profits up low-to-mid teens.
  • Specialty Chemicals: Revenue growth expected in mid-single digits; operating profits up mid-single digits.
  • Industrial Chemicals: Revenue growth expected at approximately 10%; operating profits expected to increase 60-70%.
• Capital Allocation: The Board approved a quarterly dividend increase to $0.125 per share. The company continues a $250 million share repurchase program, having spent $30 million in Q1 2008.
• Regulatory Risks:
  • Carbofuran: The U.S. EPA has proposed cancellation of all uses; FMC is defending the registration. Sales can continue through 2008 pending administrative review.
  • EU Regulations: Sales of carbofuran, carbosulfan, and cadusafos ceased in the EU in December 2007. FMC is litigating the decisions.
• Legal Contingencies: The company is appealing a €25.0 million fine from the European Commission regarding hydrogen peroxide competition law violations. A letter of credit of €27.1 million ($42.3 million) has been posted. Antitrust class actions in the U.S. and Canada regarding hydrogen peroxide and microcrystalline cellulose remain partially pending or settled.
• Environmental Obligations: Total environmental reserves are $170.8 million. The company estimates reasonably possible losses may exceed accrued amounts by approximately $75 million.

Investor Verification Checklist

• Verify the impact of the Princeton property sale ($29.6M gain) on the reported net income and assess the sustainability of earnings excluding this one-time item.
• Monitor the status of the Carbofuran regulatory proceedings in the U.S. and EU, as cancellation could materially affect future Agricultural Products revenue.
• Review the European Commission antitrust fine appeal status and the potential for additional interest accruals or penalties.
• Assess the negative operating cash flow trend and the company's reliance on asset sales and credit facilities to fund operations and capital expenditures.
• Confirm the environmental reserve adequacy given the disclosed $75 million potential exposure beyond current accruals.